18F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism

被引:31
|
作者
Pretet, Valentin [1 ]
Rotania, Marianela [1 ,2 ]
Helali, Mehdi [1 ]
Ignat, Mihaela [3 ]
Vix, Michel [3 ]
Imperiale, Alessio [1 ,4 ,5 ]
机构
[1] ICANS Univ Hosp Strasbourg, Nucl Med & Mol Imaging, F-67033 Strasbourg, France
[2] Inst Oulton, Mol & Nucl Med, X5000 JJS, Cordoba, Argentina
[3] Univ Strasbourg, IRCAD IHU, Gen Digest & Endocrine Surg, F-67033 Strasbourg, France
[4] Univ Strasbourg, Fac Med, F-67033 Strasbourg, France
[5] CNRS Unistra, IPHC, Mol Imaging DRHIM, UMR 7178, F-67033 Strasbourg, France
关键词
F-18-Fluorocholine PET; 4D contrast-enhanced CT; primary hyperparathyroidism; parathyroid; adenoma; ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; COMPUTED-TOMOGRAPHY; LOCALIZATION; SCINTIGRAPHY; MANAGEMENT; SPECT/CT; SURGERY; UPDATE;
D O I
10.3390/jcm9062005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present retrospective study evaluates the diagnostic value of integrated(18)F-Fluorocholine positron emission tomography/four-dimensional contrast-enhanced computed tomography (F-18-FCH PET/4D-CT) as second-line imaging in preoperative work-up of primary hyperparathyroidism (pHPT), and compares(18)F-FCH PET with 4D-CT. Patients with pHPT and negative/discordant first-line imaging addressed for integrated(18)F-FCH PET/4D-CT were retrospectively selected. Sensitivity and detection rate (DR%) of(18)F-FCH PET/CT, 4D-CT, and PET/4D-CT were calculated according to the per patient and per lesion analyses, and afterwards compared. Histology associated with a decrease more than 50% of perioperative parathyroid hormone (PTH) blood level was used as a gold standard. Persistent high serum PTH and calcium levels during a 6-month follow-up was considered as presence of pHPT in both operated and non-operated patients. 50 patients (55 glands) were included. 44/50 patients (88%) were surgically treated. On a per patient analysis, sensitivity was 93%, 80%, and 95%, and DR% was 82%, 68%, and 84%, respectively for PET/CT, 4D-CT, and PET/4D-CT. PET/CT was more sensitive than 4D-CT (p= 0.046). PET/4D-CT performed better than 4D-CT (p= 0.013) but was equivalent to PET/CT alone. On a per gland analysis, sensitivity PET/CT, 4D-CT, and PET/4D-CT was 88%, 66%, and 92%, and DR% was 79%, 57%, and 83%, respectively. PET/CT and PET/4D-CT were more sensitive than 4D-CT alone (p= 0.01,p< 0.001, respectively). However, PET/CT and PET/4D-CT performed similarly. In conclusion,F-18-FCH PET provides better identification of hyperfunctioning parathyroids than 4D-CT and the combination of both did not significantly improve diagnostic sensitivity. Further investigations involving larger populations are necessary to define the role of(18)F-FCH PET/4D-CT as a "one-stop shop" second-line imaging in preoperative work-up of pHPT, especially considering the additional patient radiation exposure due to multi-phase CT.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] 18F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism
    Latge, Adrien
    Riehm, Sophie
    Vix, Michel
    Bani, Jacob
    Ignat, Mihaela
    Pretet, Valentin
    Helali, Mehdi
    Treglia, Giorgio
    Imperiale, Alessio
    DIAGNOSTICS, 2021, 11 (12)
  • [2] Dual time 18F-Fluorocholine PET/CT in patients with primary hyperparathyroidism
    Vija, L.
    Latge, A.
    Sinigaglia, M.
    Renaud, C.
    Grunenwald, S.
    Pascal, P.
    Kanoun, S.
    Zerdoud, S.
    Brillouet, S.
    Cassou-Mounat, M. Terroir
    Mounat, T. Cassou
    Dierickx, L. O.
    Courbon, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S358 - S359
  • [3] 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism
    Dudoignon, David
    Delbot, Thierry
    Cottereau, Anne Segolene
    Dechmi, Amina
    Bienvenu, Marie
    Koumakis, Eugenie
    Cormier, Catherine
    Gaujoux, Sebastien
    Groussin, Lionel
    Cochand-Priollet, Beatrix
    Clerc, Jerome
    Wartski, Myriam
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2022, 103 (05) : 258 - 265
  • [4] 18F-Fluorocholine PET/CT in persistent/recurrent primary hyperparathyroidism
    Naik, M.
    Khan, S. R.
    Patel, N. H.
    Perry, L.
    Alsafi, A.
    Harvey, C.
    Alves, L.
    Palazzo, F.
    Barwick, T. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S420 - S420
  • [5] Identification of Occult Adenomas in Primary Hyperparathyroidism With 18F-fluorocholine PET/CT
    Ballester Vazquez, Eulalia
    Perez Garcia, Jose Ignacio
    Lopez Mora, Diego Alfonso
    Galan Martinez, Clara
    Pareja Nieto, Elena
    Clos Enrriquez, Montserrat
    Gonzalez Lopez, Jose Antonio
    Moral Duarte, Antonio
    CIRUGIA ESPANOLA, 2020, 98 (07): : 395 - 402
  • [6] Lincoln Sign in a Case of Primary Hyperparathyroidism on 18F-Fluorocholine PET/CT
    Prakash, Sneha
    Damle, Nishikant Avinash
    Kumar, Praveen
    Dharmashaktu, Yamini
    Bal, C. S.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (07) : E343 - E344
  • [7] The utility of 18F-Fluorocholine PET/CT in renal hyperparathyroidism
    Shankar, K.
    Kumar, S.
    Krishnaraju, V.
    Kumar, R.
    Singh, H.
    Mittal, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S418 - S418
  • [8] Incidental Detection of a Melanoma by 18F-Fluorocholine PET/CT Performed for Evaluation of Primary Hyperparathyroidism
    Burgers, Anne Marij Geertruida
    Wondergem, Maurits
    van der Zant, Friso Martijn
    Knol, Remco Johannes Jacob
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 265 - 266
  • [9] Preoperative Imaging with [18F]-Fluorocholine PET/CT in Primary Hyperparathyroidism
    Dekorsy, Franziska J.
    Beyer, Leonie
    Spitzweg, Christine
    Schmidmaier, Ralf
    Todica, Andrei
    Trupka, Arnold
    Cyran, Clemens C.
    Berger, Frank
    Ladurner, Roland
    Zimmermann, Petra
    Knoesel, Thomas
    Bartenstein, Peter
    Lottspeich, Christian
    Wenter, Vera
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [10] 18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism
    Mathieu Gauthé
    Anne Dierick-Gallet
    Thierry Delbot
    Léopoldine Bricaire
    Jérôme Bertherat
    Marie-Odile North
    Beatrix Cochand-Priollet
    Phillipe Bouchard
    Jean-Noël Talbot
    Lionel Groussin
    Sébastien Gaujoux
    World Journal of Surgery, 2020, 44 : 3761 - 3769